(Q45757535)

15 December 2017

title

BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic (English)

1 reference

15 December 2017

main subject

Czech Republic

0 references

papillary thyroid cancer

1 reference

V Sykorova

1

1 reference

15 December 2017

S Dvorakova

2

1 reference

15 December 2017

A Ryska

3

1 reference

15 December 2017

J Vcelak

4

1 reference

15 December 2017

E Vaclavikova

5

1 reference

15 December 2017

J Laco

6

1 reference

15 December 2017

D Kodetova

7

1 reference

15 December 2017

R Kodet

8

1 reference

15 December 2017

A Cibula

9

1 reference

15 December 2017

J Duskova

10

1 reference

15 December 2017

A Hlobilkova

11

1 reference

15 December 2017

J Astl

12

1 reference

15 December 2017

D Vesely

13

1 reference

15 December 2017

J Betka

14

1 reference

15 December 2017

J Hoch

15

1 reference

15 December 2017

S Smutny

16

1 reference

15 December 2017

J Cap

17

1 reference

15 December 2017

P Vlcek

18

1 reference

15 December 2017

Z Novak

19

1 reference

15 December 2017

B Bendlova

20

1 reference

15 December 2017

publication date

4 December 2009

1 reference

15 December 2017

Journal of Endocrinological Investigation

published in

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

5

1 reference

15 December 2017

page(s)

318-324

1 reference

15 December 2017

NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Gene rearrangement and Chernobyl related thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

High frequency of BRAF mutations in nevi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF and KRAS mutations in stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

The Raf/MEK/ERK pathway: new concepts of activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutations in papillary carcinomas of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF T1796A transversion mutation in various thyroid neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutations in an Italian cohort of thyroid cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

The prevalence and prognostic value of BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

TNM staging of cancers of the head and neck: striving for uniformity among diversity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Molecular profile of hyalinizing trabecular tumours of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Chemometrics in metabonomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Thyroid cancer after Chernobyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Thyroid cancer in the Ukraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346593

Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children.

21 January 2018

1 reference

12 December 2020

Thyroid cancer has increased in the adult populations of countries moderately affected by Chernobyl fallout

1 reference

12 December 2020

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

12 December 2020

The oncogene BRAFV600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I− targeting to the membrane

1 reference

12 December 2020

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma

1 reference

12 December 2020

High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant

1 reference

12 December 2020

BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.

1 reference

12 December 2020

High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma

1 reference

12 December 2020

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

1 reference

12 December 2020

BRAF Mutation in Papillary Thyroid Carcinoma

1 reference

12 December 2020

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

1 reference

12 December 2020

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 reference

12 December 2020

Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.

1 reference

12 December 2020

BRAFMutations Are Not a Major Event in Post-Chernobyl Childhood Thyroid Carcinomas

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03346593

1 reference

15 December 2017

Dimensions Publication ID

1000452148

0 references

1 reference

15 December 2017